Kyverna Therapeutics Inc.. (KYTX) NASDAQ
$15.25 (0.62) (-3.91%)
Market Cap: $684.24M
As of 05/16/24 04:00 PM EDT. Market closed.
Kyverna Therapeutics Inc.. (KYTX)
NASDAQ
$15.25
(0.62) (-3.91%)
Market Cap: $684.24M
As of 05/16/24 04:00 PM EDT. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
PRICE CHART FOR KYVERNA THERAPEUTICS INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$16.11
Previous Close
$15.87
Days Range
$15.53 - $17.55
52 week range
$12.26 - $35.06
Volume
134,983
Avg. Volume (30 days)
452,509
Market Cap
$684.24M
Dividend Yield
-
P/E
-
Shares Outstanding
43,115,244
Open
$16.11
Previous Close
$15.87
Days Range
$15.53 - $17.55
52 week range
$12.26 - $35.06
Volume
134,983
Avg. Volume (30 days)
452,509
Market Cap
$684.24M
Dividend Yield
-
P/E
-
Shares Outstanding
43,115,244
FINANCIAL STATEMENTS FOR KYVERNA THERAPEUTICS INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR KYVERNA THERAPEUTICS INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Vida Ventures, LLC | 10% Owner | Feb 12, 2024 | Buy | $22.00 | 583 | 12,826 | 583 | Feb 14, 2024, 07:04 PM |
| Vida Ventures, LLC | 10% Owner | Feb 12, 2024 | Buy | $22.00 | 252,553 | 5,556,166 | 252,553 | Feb 14, 2024, 07:04 PM |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | Feb 12, 2024 | Buy | $22.00 | 450,000 | 9,900,000 | 3,163,868 | Feb 14, 2024, 05:26 PM |
| GILEAD SCIENCES, INC. | 10% Owner | Feb 12, 2024 | Buy | $22.00 | 910,000 | 20,020,000 | 4,126,119 | Feb 13, 2024, 05:48 PM |
| Northpond Ventures III GP, LLC | Former 10% Owner | Feb 12, 2024 | Buy | $22.00 | 450,000 | 9,900,000 | 450,000 | Feb 12, 2024, 05:51 PM |
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Vida Ventures, LLC | 10% Owner | 02/12/2024 | 12,826 |
| Vida Ventures, LLC | 10% Owner | 02/12/2024 | 5,556,166 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | 02/12/2024 | 9,900,000 |
| GILEAD SCIENCES, INC. | 10% Owner | 02/12/2024 | 20,020,000 |
| Northpond Ventures III GP, LLC | Former 10% Owner | 02/12/2024 | 9,900,000 |
FUNDS WITH A POSITION IN KYVERNA THERAPEUTICS INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,462,337 | 0.63% | New | Other |
| BLACKROCK INC. | 749,966 | 0.00043% | New | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 575,000 | 0.03% | New | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 172,236 | 0.0004% | New | Other |
| BLACKSTONE INC. | 100,000 | 0.01% | New | Other |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20,000 | 0.00849% | New | Event Driven |
| BALYASNY ASSET MANAGEMENT L.P. | 16,721 | 0.00073% | New | Event Driven |
| TUDOR INVESTMENT CORP ET AL | 8,492 | 0.00134% | New | Event Driven, Other |
CHANGE IN SHARES OUTSTANDING FOR KYVERNA THERAPEUTICS INC.
STOCK BUYBACKS FOR KYVERNA THERAPEUTICS INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2022
49.79%
4Q
BUYBACK ANNOUNCEMENT(S) FOR KYVERNA THERAPEUTICS INC.
LOADING...